SFM

Sphera Funds Management Portfolio holdings

AUM $382M
This Quarter Return
-8.63%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$604M
AUM Growth
+$604M
Cap. Flow
-$57.3M
Cap. Flow %
-9.5%
Top 10 Hldgs %
56.78%
Holding
110
New
23
Increased
21
Reduced
26
Closed
29

Sector Composition

1 Healthcare 87.4%
2 Technology 6%
3 Consumer Discretionary 1.7%
4 Communication Services 0.44%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
APLT icon
51
Applied Therapeutics
APLT
$71M
$2.22M 0.28% +67,967 New +$2.22M
PRQR icon
52
ProQR Therapeutics
PRQR
$237M
$1.9M 0.24% 346,148 -458,852 -57% -$2.52M
NEOS
53
DELISTED
Neos Therapeutics, Inc
NEOS
$1.88M 0.24% 2,509,468 -1,021,263 -29% -$766K
KALV icon
54
KalVista Pharmaceuticals
KALV
$678M
$1.84M 0.23% 240,140 +92,440 +63% +$707K
VRTX icon
55
Vertex Pharmaceuticals
VRTX
$100B
$1.67M 0.21% +7,000 New +$1.67M
IMVTU
56
DELISTED
Immunovant, Inc. Units
IMVTU
$1.56M 0.2% 94,500 -5,500 -6% -$91K
ARGX icon
57
argenx
ARGX
$43.6B
$1.35M 0.17% 10,265 -6,316 -38% -$832K
GBT
58
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.27M 0.16% +24,752 New +$1.27M
NERV icon
59
Minerva Neurosciences
NERV
$16.5M
$1.01M 0.13% 168,357 -686,643 -80% -$4.14M
LPTX icon
60
Leap Therapeutics
LPTX
$12M
$948K 0.12% +600,000 New +$948K
DTIL icon
61
Precision BioSciences
DTIL
$57.8M
$889K 0.11% 147,352 -346,387 -70% -$2.09M
APTX
62
DELISTED
Aptinyx Inc. Common Stock
APTX
$889K 0.11% +411,666 New +$889K
SNDX icon
63
Syndax Pharmaceuticals
SNDX
$1.41B
$747K 0.09% +68,134 New +$747K
ALNA
64
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
$643K 0.08% 667,800 -250,000 -27% -$241K
STOK icon
65
Stoke Therapeutics
STOK
$1.08B
$624K 0.08% 27,254 -229,126 -89% -$5.25M
ISEE
66
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$425K 0.05% 123,424 -744,776 -86% -$2.56M
ZYNE
67
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$383K 0.05% +100,000 New +$383K
CYCN icon
68
Cyclerion Therapeutics
CYCN
$7.91M
$331K 0.04% +124,976 New +$331K
VIRX
69
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$299K 0.04% 721,800 -1,420,000 -66% -$588K
IMVT icon
70
Immunovant
IMVT
$2.56B
$296K 0.04% 19,032 -968 -5% -$15.1K
BMY.RT
71
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$190K 0.02% +50,000 New +$190K
OTLKW
72
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$130K 0.02% +129,500 New +$130K
MIST icon
73
Milestone Pharmaceuticals
MIST
$156M
$125K 0.02% +67,992 New +$125K
CLRB icon
74
Cellectar Biosciences
CLRB
$15.5M
$111K 0.01% 87,500
PTCT icon
75
PTC Therapeutics
PTCT
$3.92B
-214,736 Closed -$10.3M